ClinicalTrials.Veeva

Menu

Cortical Excitability and Role of rTMS in Cannabis Use Disorder

A

Assiut University

Status and phase

Unknown
Early Phase 1

Conditions

Cannabis Use Disorder, Moderate

Treatments

Device: rTMS

Study type

Interventional

Funder types

Other

Identifiers

NCT04106336
rTMS in cannabis use disorder

Details and patient eligibility

About

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder

Enrollment

60 estimated patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18to 50 years of age
  • cannabis use disorder according to DSM 5 definition
  • clear consent to participate in study

Exclusion criteria

  • cardiac peacemaker
  • metal implant in the head as participate will be applied to magnetic field of TMS
  • current intake of any medication affect cognition (as anti psychotic and anti epileptic)
  • current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
  • age younger than 18 and older than 50 years

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 2 patient groups

non cannabis addict
No Intervention group
Description:
30 non cannabis addict will be control group
cannabis addict
Active Comparator group
Description:
30 cannabis addict will undergo rTMS
Treatment:
Device: rTMS

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems